Search Results - "Turci D"

PRIMARY OVARIAN CARCINOID PRESENTING AS ACUTE ABDOMEN

Authors: de Giorgi, U. Turci, D. Papiani, G. et al.

Source: Clinical Oncology. Oct2002, Vol. 14 Issue 5, p432. 1p.

A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization.

Authors: Kopf, B. De Giorgi, U. Vertogen, B. et al.

Source: Bone Marrow Transplantation. Sep2006, Vol. 38 Issue 6, p407-412. 6p. 3 Charts.

Role of biological markers in the clinical outcome of colon cancer.

Authors: Nanni, O. Volpi, A. Frassineti, G L et al.

Source: British Journal of Cancer. 10/7/2002, Vol. 87 Issue 8, p868-875. 8p.

5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.

Authors: Sobrero, A Guglielmi, A Cirillo, M et al.

Source: British Journal of Cancer. 4/15/2001, Vol. 84 Issue 8, p1023. 6p.

Peripheral blood progenitor cell (PBPC) mobilization in heavily pretreated patients with germ cell tumors: a report of 34 cases.

Authors: Dazzi, C Cariello, A Rosti, G et al.

Source: Bone Marrow Transplantation. 3/15/99, Vol. 23 Issue 6, p529. 4p.

Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial.

Authors: Passardi, A. Nanni, O. Tassinari, D. et al.

Source: Annals of Oncology. Jun2015, Vol. 26 Issue 6, p1201-1207. 7p. 2 Diagrams, 2 Charts, 1 Graph.

Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised ‘GISCAD’ trial.

Authors: Labianca, R. Sobrero, A. Isa, L. et al.

Source: Annals of Oncology. May2011, Vol. 22 Issue 5, p1236-1242. 7p. 1 Diagram, 4 Charts, 1 Graph.

53PImmune-related adverse events correlate with clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with nivolumab in the Italian expanded access programme.

Authors: Baldini, E Lunghi, A Cortesi, E et al.

Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population.

Authors: Crinò L Bidoli P Delmonte A et al.

Source: The oncologist [Oncologist] 2019 Nov; Vol. 24 (11), pp. e1165-e1171. Date of Electronic Publication: 2019 Apr 17.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.

Authors: De Giorgi U Cartenì G Giannarelli D et al.

Corporate Authors: De Giorgi U Cartenì G Giannarelli D et al.

Source: BJU international [BJU Int] 2019 Jan; Vol. 123 (1), pp. 98-105. Date of Electronic Publication: 2018 Jul 23.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int

Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program.

Authors: Baldini E Lunghi A Cortesi E et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2020 Feb; Vol. 140, pp. 59-64. Date of Electronic Publication: 2019 Dec 20.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.

Authors: Ruzzo A Graziano F Galli F et al.

Source: Scientific reports [Sci Rep] 2020 Jan 31; Vol. 10 (1), pp. 1918. Date of Electronic Publication: 2020 Jan 31.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; PubMed not MEDLINE

Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer.

Authors: Grossi F Genova C Crinò L et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Dec; Vol. 123, pp. 72-80. Date of Electronic Publication: 2019 Oct 28.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.

Authors: Ruzzo A Graziano F Galli F et al.

Source: Scientific reports [Sci Rep] 2019 Aug 08; Vol. 9 (1), pp. 11527. Date of Electronic Publication: 2019 Aug 08.

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Equivalence Trial

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Ovarian Sertoli-Leydig cell tumor, endometrioid-like yolk sac tumor, and Y-chromosomal material.

Authors: De Giorgi U Turci D Crisanti E et al.

Source: Oncology [Oncology] 2003; Vol. 64 (4), pp. 370-3.

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print Cited Medium: Print ISSN: 0030-2414 (Print) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program.

Authors: Verzoni E Cartenì G Cortesi E et al.

Corporate Authors: Verzoni E Cartenì G Cortesi E et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Apr 03; Vol. 7 (1), pp. 99. Date of Electronic Publication: 2019 Apr 03.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience.

Authors: Rihawi K Giannarelli D Galetta D et al.

Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2019 Mar; Vol. 14 (3), pp. e57-e59.

Publication Type: Letter; Comment

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations.

Authors: Passiglia F Cappuzzo F Alabiso O et al.

Source: British journal of cancer [Br J Cancer] 2019 Jan; Vol. 120 (1), pp. 57-62. Date of Electronic Publication: 2018 Oct 31.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Use of nivolumab in elderly patients with advanced squamous non-small-cell lung cancer: results from the Italian cohort of an expanded access programme.

Authors: Grossi F Crinò L Logroscino A et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2018 Sep; Vol. 100, pp. 126-134. Date of Electronic Publication: 2018 Jul 13.

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Italian Nivolumab Expanded Access Program in Nonsquamous Non-Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients.

Authors: Garassino MC Gelibter AJ Grossi F et al.

Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2018 Aug; Vol. 13 (8), pp. 1146-1155. Date of Electronic Publication: 2018 May 03.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE